|
Match
|
Document |
Document Title |
|
|
4774258 |
Treatment of urinary calculi
Urinary calculi commonly known as kidney stones are eliminated by the oral administration of triglycine or other suitable chelating agent in amounts appropriate to either the solubilization of...
|
|
|
4767786 |
Disinfectant and cleansing composition
A disinfectant and cleansing composition is provided which contains as primary active ingredient an alkali metal salt of a hydroxy alkyl amine-substituted carboxylic acid, e.g., sodium dihydroxy...
|
|
|
4767785 |
Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
Isotonic hypocaloric preparation comprising essential dietary amino acids with or without nonessential dietary amino adies, and xylitol, and method of treating patients ill from renal failure,...
|
|
|
4767784 |
Novel crystalline salts of aryloxy-propanolamines, a process for their preparation and their use
The invention relates to novel crystalline salts of aryloxypropanolamines with diphenylacetic acid, a process for their preparation and the use of these salts for the preparation of chemically pure...
|
|
|
4764531 |
Method of feeding ketoisocaproate to laying chickens
A method of feeding laying chickens to increase egg production and/or reduce yolk cholesterol is provided in which alpha-ketoisocaproate (KIC) is orally administered to the laying chickens...
|
|
|
4761429 |
Enkephalinase and endorphinase inhibitors as anti-craving compositions
A new class of anti-craving compositions is provided by substances which inhibit breakdown of endogenous substances such as enkephalins and/or endorphins. An anti-alcohol craving effect is observed...
|
|
|
4760091 |
Method of controlling phytopathogenic fungus
This invention relates to a method of controlling phytopathogenic rust and smut fungi of the Uredinales order in a plant locus which comprises applying a fungicidally effective amount of an...
|
|
|
4755533 |
Topical vaginal use of lysine p-isobutylphenylpropionate in anti-inflammatory treatment
This invention relates to the vaginal topical use of lysine p-isobutylphepropionate in local and targeted anti-inflammatory treatment of pathologies of obstetric and gynelogical type. Said use is...
|
|
|
4753804 |
Granular dietetic product based on amino acids and process for their preparation
Dietetic formulations for oral use are described, made up of compact pellets of mixtures of α-amino acids, possibly coated by a waterproof protective film, which may be disgregated in the...
|
|
|
4735968 |
Method of treating tinnitus with AOAA
Tinnitus symptoms are treated with aminooxyacetic acid (AOAA) administered orally at dosages of 200-300 mg/day. Clinically significant reductions in tinnitus symptoms were observed.
|
|
|
4732892 |
L-α-amino acids as transdermal penetration enhancers
The disclosed invention provides methods and compositions ulilizing L-α-amino acids for enhancing the rate of penetration through the skin of both topical medicaments and of drugs employed for...
|
|
|
4730006 |
Derivatives of 2,6-diamino-3-haloheptanedioic acid
This invention relates to amino acid, dipeptide and tripeptide derivatives of 2,6-diamino-3-haloheptanedioic acids, processes for preparing the same, and their use as antibacterial agents.
|
|
|
4730007 |
Novel analgesic compositions
An analgesic composition comprising an effective amount of an analgesic, anti-inflammatory agent selected from the group consisting of D-phenylalanine, DL-phenylalanine, D-leucine, DL-leucine and...
|
|
|
4724234 |
Method for producing oncolysis
A method of producing oncolysis and regression of malignant tumors and other malignant conditions without adverse effects on normal body cells is described. A calorically and compositionally...
|
|
|
4716153 |
Stable oral preparation of macrolide antibiotics and method for stabilizing the same
Stable oral preparations of 16-membered ring macrolide antibiotics such as SF-837, josamycin, 3"-propionyljosamycin, by incorporating stabilizers showing pH 3-10 in an aqueous medium, such as...
|
|
|
4713370 |
Carnitine and its use in reducing cardiac toxicity and as a synergist with cytostats
Carnitine may be administered for the purpose of reducing cardiac toxicity resulting from administration of a cytostat. Carnitine may also be administered in combination with cytostats to produce...
|
|
|
4711906 |
Liquid diclofenac preparations
Disclosed are aqueous, stable, relatively concentrated solutions of diclofenac, which contain a mixture of propylene glycol and polyethylene glycol in defined quantitative proportions. The...
|
|
|
4699902 |
Process for the production of readily soluble 5-aminosalicylic acid preparations
The invention relates to a process for the production of pharmaceutical preparations based on 5-aminosalicylic acid in which the 5-aminosalicylic acid is mixed with physiologically and...
|
|
|
4696946 |
Topical Treatment of hyperproliferative skin diseases
A method for the topical treatment of hyperproliferative skin diseases in a human is described. Compounds and compositions for use in this method are also described.
|
|
|
4695588 |
Fluorinated amino acids
Novel substituted α-fluoromethyl-α-amino alkanoic acids and esters thereof are disclosed. The novel compounds have biological activity including decarboxylase inhibition.
|
|
|
4690949 |
Therapeutic drug for dementia
A therapeutic drug for dementia is provided which comprises, as an active ingredient, DL- or L-threo-3,4-dihydroxyphenylserine of the formula ##STR1## or its salt.
|
|
|
4689218 |
Effervescent composition with analgesic activity
It is described an effervescent composition consisting of: Ibuprofen 9-17% w/w Arginine 17-33% w/w Sodium or potassium bicarbonate 20-35% w/w Sodium bitartrate 25-40% w/w Such...
|
|
|
4687782 |
Nutritional composition for enhancing skeletal muscle adaptation to exercise training
A combination of amino acids (carnitine, glutamine, isoleucine, leucine and valine) provide diet supplements which employ branched amino acids (BAA) to promote muscle adaptation to strenuous...
|
|
|
4687781 |
Analgesic and anti-inflammatory compositions
Analgesic and anti-inflammatory compositions are provided which comprise a therapeutically effective amount of a hydrocinnamic acid alone, or in combination with one or more amino acids selected...
|
|
|
4680311 |
Method for the treatment of systemic mycosis
Method for the treatment of systemic mycosis of mammals comprises administering (S)-2-amino-5-hydroxy-4-oxopentanoicacid in a therapeutically effective amount to said mammals suffering from...
|
|
|
4677121 |
Method of inhibiting muscle protein degradation
Muscle protein breakdown or degradation may be reduced or inhibited in mammals, particularly humans recovering from surgery or suffering from a muscle wasting disorder, by administering daily doses...
|
|
|
4675339 |
Spherical amino acid preparation
The present invention relates to a spherical amino acid having an average particle size of about 1 mm or below and a process for the preparation thereof.
|
|
|
4673534 |
Carnitine salts particularly suitable for oral use
New carnitine salts with sulphonic acids, of general formula: ##STR1## in which R is a linear or branched alkyl chain of 8 to 18 carbon atoms, and which are particularly suitable for oral use. Said...
|
|
|
4673689 |
Method and composition for enhancing the effect of indirect-acting sympathomimetic amines
Tyrosine or a tyrosine precursor is administered concomitantly with an indirect-acting sympathomimetic amine drug to increase the level of norepinephrine that can be released in sympathetic neuron...
|
|
|
4670466 |
R-(Z)-4-amino-3-chloro-2-pentenedioic acid, novel antibacterial agent
R-(Z)-4-amino-3-chloro-2-pentenedioic acid is a novel antibacterial and isolated from Streptomyces viridogenes MA5450, ATCC 39387.
|
|
|
4670261 |
Parenteral alimentation solution
A parenteral alimentation solution having excellent nutritional properties with preventing problems such as browning which comprises three components of a reducing sugar, amino acids and...
|
|
|
4668665 |
Formulation of sucralfate
A storage-stable sucralfate-containing preparation which maintains its ability, even after extended periods of time, to form a viscous, sticky, paste-like material in the presence of gastric...
|
|
|
4668703 |
γ-allenyl-γ-aminobutyric acids
This invention is for γ-allenyl-γ-aminobutyric acid derivatives which are γ-aminobutyric acid transaminase inhibitors.
|
|
|
4650668 |
Composition for relieving toothache pain and other forms of intense pain
A treatment for temporary relief of pain wherein a single dose comprises the following: 4 grams calcium gluconate by injection, 1 gram Vitamin C (calcium ascorbate), 100 mg magnesium hydroxide, 50...
|
|
|
4638013 |
Dietetic supplement and prepackaged food in which it is contained, process of preparation and method of administration
A completely tryptophan-free dietetic supplement based on amino acids, which has an effect on sleep, comprising at least L-isoleucine (4-16%), L-leucine (9-27%), L-lysine (7-20%), L-methionine...
|
|
|
4614741 |
Depot antiinflammatory agents
The invention relates to depot formulations containing, as an active antiinflammatory and/or analgesic agent a compound of Formula I, infra together with a suspension medium. Typical suspension...
|
|
|
4605557 |
Method of producing allergenic extracts
A method for the production of allergenic extracts comprising the extraction of an allergenic substance with a suitable solvent having incorporated therein a small but effective amount of a...
|
|
|
4604286 |
Infusion solution for parenteral nutrition
Infusion solutions for parenteral nutrition which contain amino acids, dextrose and electrolytes.
|
|
|
4602039 |
Salts of-carnitine and alkanoyl L-carnitines and process for preparing same
Novel L-carnitine and alkanoyl L-carnitine salts and a process for their preparation are disclosed. The salts have the general formula ##STR1## wherein X - is an anion of acid aspartate, acid...
|
|
|
4600582 |
Therapeutic treatment
A method of reducing local adverse reactions which occur at the site of administration of parenterally administrable physiologically active compositions, to patients which comprises, prior to...
|
|
|
4600583 |
Pharmaceutical compositions
The method of improving the storage stability of parenterally administerable physiologically active compositions which comprises, incorporating in said compositions a small but effective amount of...
|
|
|
4596825 |
Method of treating liver disturbances resulting from alcohol consumption and a composition therefor
A pharmaceutical composition for preventing or alleviating the effects of acute alcoholism, in particular liver disturbances in mammals, which comprises a mixture of alanine or a pharmaceutically...
|
|
|
4593044 |
Injectable solution for the treatment of inflammations
The invention relates to the use of naproxen lysinate, ketoprofen lysinate and/or diclofenac lysinate in the form of an injectable solution in the treatment of inflammations and rheumatic...
|
|
|
4579869 |
Substituted [(2,3-dihydro-1-oxo-1H-inden-5-yl)amino]alkanoic acids, their derivatives and their salts
The invention relates to novel substituted [(2,3-dihydro-1-oxo-1H-inden-5-yl)amino]alkanoic acids, their derivatives and their salts. The compounds are useful for the treatment and prevention of...
|
|
|
4567045 |
Isotonic glycerol free intravenous fat emulsion
Sterile, glycerol free lipid emulsion suitable for parenteral administration and including alanine in an amount sufficient to provide pharmaceutically acceptable osmolality.
|
|
|
4563478 |
Method of tranquilizing
The invention relates to compounds possessing GABA-like sedative and tranquilizing activity, characterized by being of general formula: X 1 OC--(CH 2 ) 2 --NH--(CH 2 ) 3 --CO--X 2 where X 1...
|
|
|
4560553 |
Use of eucalyptol for enhancing skin permeation of bio-affecting agents
Eucalyptol is used to enhance skin permeation of bio-affecting agents.
|
|
|
4552898 |
[3.2.0]Bicycloheptanone oxime ethers with valuable therapeutic properties
Compounds useful in treating cardiovascular disorders are the carboxylic acids depicted in formulas (1) and (2) ##STR1## as well as their pharmaceutically acceptable, non-toxic salts and esters,...
|
|
|
4551473 |
Method of inhibiting snoring and obstructive sleep apnea
Snoring and obstructive sleep apnea are relieved in most instances by administering an effective dose of a muscle relaxant that acts at the spinal or supra-spinal level. A presently preferred drug...
|
|
|
4537772 |
Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
Acylcarnitines used as drug absorption enhancing agents for orally and rectally administered drugs.
|